Can Seizure Medication Make Rolandic Epilepsy or ESES Worse?
At a Glance
Oxcarbazepine and carbamazepine may rarely increase abnormal brain-wave spikes during sleep in children with Rolandic epilepsy, sometimes contributing to ESES/SWAS and loss of skills. Most children do not have this reaction; a neurologist should guide any medication change.
In this answer
3 sections
Yes, certain anti-seizure medications—specifically sodium-channel blockers like oxcarbazepine and carbamazepine—have been reported in some cases to worsen the electrical disturbances in the brain associated with Rolandic epilepsy [1]. While many children take these medications safely and effectively, there is an uncommon possibility that they can aggravate sleep-time electrical spikes and potentially contribute to a condition called Encephalopathy with Status Epilepticus in Sleep (ESES) or Spike-Wave Activation in Sleep (SWAS) [2][1]. Because of this possibility, doctors monitor children starting these medications for any sudden changes in learning, behavior, or seizure types. It is important to remember that most children do not experience this, and any medication changes must be made with medical supervision.
The Paradox: When Treatment Worsens Symptoms
Parents are often alarmed to learn that a medication meant to stop seizures might potentially worsen the condition. In self-limited epilepsy with centrotemporal spikes (SeLECTS, the current medical name for Rolandic epilepsy), seizures typically happen at night or upon waking, though they can occasionally occur during the day.
While medications like oxcarbazepine and carbamazepine are commonly used to control focal seizures, observational experience and select case reports suggest they can sometimes cause a “paradoxical aggravation” [3]. This means that rather than calming the brain’s electrical activity, the medication may be associated with an increase in abnormal electrical discharges (spikes) during sleep [1][4].
From Rolandic Epilepsy to ESES / SWAS
During non-rapid eye movement (NREM) sleep, the brain normally synchronizes its networks. In children with SeLECTS, sleep-activated spikes can occur. In rare cases, these spikes can become near-continuous during sleep. This EEG pattern is called ESES (Electrical Status Epilepticus in Sleep) or SWAS (Spike-Wave Activation in Sleep) [2]. Note that ESES is a pattern seen on an EEG, not a continuous physical convulsion or convulsive status epilepticus.
When near-continuous spikes disrupt sleep, a child might experience cognitive and behavioral regression—a loss of previously acquired skills [5]. The exact biological mechanism for why sodium-channel blockers might trigger this in some children is still debated, though some researchers hypothesize these drugs might inadvertently enhance certain excitatory signals in the brain [6].
It is essential to understand that causality and frequency are not fully established. Many children take oxcarbazepine or carbamazepine with excellent seizure control and no negative effects [7]. The clearest direct evidence of this medication risk comes from case reports where a child rapidly developed cognitive deterioration and ESES shortly after starting the medication, and then improved after the drug was stopped [1]. However, progression to SWAS can also happen as part of the natural evolution of the underlying epilepsy, regardless of medication [8].
Signs of Worsening to Watch For
Because of this potential risk, evaluating treatment for SeLECTS involves looking beyond visible seizures to monitor your child’s learning and behavior [9].
If your child is starting a medication like oxcarbazepine, watch for sudden, persistent, or progressive loss of previously acquired skills. Note that some symptoms can also just be ordinary medication side effects (like sleepiness or dizziness) or signs of typical school stress. However, concerning signs of cognitive or behavioral regression include:
- Academic Decline: A sudden, persistent drop in school performance, or loss of reading or math skills they had already mastered [10][5].
- Language Difficulties: Trouble finding the right words, speaking in simpler sentences, or trouble understanding instructions [11][12].
- Behavioral Changes: Severe, new restlessness, poor attention span, or irritability [10].
- Motor Problems: Sudden, frequent falls or repeatedly dropping objects. While this could be dizziness from medication, it could also be a type of seizure called epileptic negative myoclonus (a brief loss of muscle tone) [13][14].
- Changes in Seizures: A noticeable increase in seizure frequency, new types of daytime seizures, or new daytime staring spells [15].
What to Do If You Suspect a Problem
If you notice signs of developmental regression or a change in seizures, contact your child’s neurologist to arrange a prompt evaluation [16]. Keep a log of your child’s symptoms, sleep patterns, and when medication doses were changed.
When to Seek Emergency Help
Not all changes are emergencies. However, you should call emergency services (like 911) or follow your child’s emergency seizure action plan if your child has:
- A seizure lasting 5 minutes or longer
- Repeated seizures without waking up in between
- Difficulty breathing during or after a seizure
- A serious injury during a seizure
Medical Evaluation
Do not stop or change the dose of the medication on your own. Abruptly stopping seizure medications can be dangerous.
If cognitive regression is suspected, your doctor may order an EEG that captures non-REM sleep [17][18]. A standard 20-minute awake EEG might not be enough to detect ESES because the spikes primarily happen during NREM sleep [19][18]. While an overnight study is sometimes used, a routine EEG that successfully captures a sufficient amount of sleep can also be informative.
If the sleep EEG shows ESES/SWAS and is accompanied by clinical regression, your pediatric neurologist may carefully taper the suspected medication and discuss alternative treatment options [20][1]. There is no single “best” alternative—every medication has its own profile. For instance, levetiracetam can sometimes cause behavioral irritability, valproic acid carries liver and reproductive risks, and clobazam can cause sedation [20][16]. Your doctor will individualize the treatment plan based on the EEG results, seizure burden, and your child’s specific needs.
Common questions in this guide
Can oxcarbazepine or carbamazepine make Rolandic epilepsy worse?
What are ESES and SWAS in childhood epilepsy?
What changes could suggest worsening in a child with Rolandic epilepsy?
Why does an EEG need to capture sleep when ESES is suspected?
How might treatment change if a sleep EEG shows ESES or SWAS?
When should a child with a seizure change receive emergency help?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.If my child experiences a sudden change in learning or behavior, how quickly can we get an EEG that captures sufficient non-REM sleep?
- 2.What specific behavioral or academic changes should prompt us to call you rather than waiting for our next appointment?
- 3.How can we distinguish between normal medication side effects (like sleepiness or dizziness) and signs of cognitive regression or ESES?
- 4.If the sleep EEG shows SWAS, what are our alternative medication options, and what are the risks and benefits of each?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (20)
- 1
Encephalopathy with status epilepticus during sleep (ESES) induced by oxcarbazepine in idiopathic focal epilepsy in childhood.
Pavlidis E, Rubboli G, Nikanorova M, et al.
Functional neurology 2015; (30(2)):139-41 doi:10.11138/fneur/2015.30.2.139.
PMID: 26415787 - 2
Evolution into spike-and-wave activation in sleep in patients with self-limited focal epilepsies.
İriş M, Yaşgüçlükal MA, Yalçınkaya C, Demirbilek V
Seizure 2026; (135()):34-38 doi:10.1016/j.seizure.2026.01.006.
PMID: 41570778 - 3
Suspected induction of epileptic negative myoclonus after lacosamide initiation.
Yamamoto N, Kuki I, Inoue T, et al.
Epilepsia 2025; (66(10)):e226-e231 doi:10.1111/epi.18595.
PMID: 40956034 - 4
A Case of Carbamazepine-Induced Aggravation of Self-Limited Epilepsy with Centrotemporal Spikes Epilepsy and Valproate-Induced Hyperammonemic Encephalopathy in a Child with Heterozygous Gene Variant of Carbomoyl Phosphatase Synthetase Deficiency.
Kankananarachchi I, Jasinge E, Hewawitharana G
Case reports in neurological medicine 2021; (2021()):2362679 doi:10.1155/2021/2362679.
PMID: 35003817 - 5
Successful Treatment of a Child With Epileptic Encephalopathy With Spike-Wave Activation in Sleep and GRIN2A Variant Using Sulthiame.
Pereira-Nunes J, Sousa JM, Fonseca J, et al.
Cureus 2023; (15(2)):e34686 doi:10.7759/cureus.34686.
PMID: 36909045 - 6
Carbamazepine and oxcarbazepine, but not eslicarbazepine, enhance excitatory synaptic transmission onto hippocampal CA1 pyramidal cells through an antagonist action at adenosine A1 receptors.
Booker SA, Pires N, Cobb S, et al.
Neuropharmacology 2015; (93()):103-15.
PMID: 25656478 - 7
A Multicenter Study of Self-Limited Epilepsy With Centrotemporal Spikes: Effectiveness of Antiseizure Medication With Respect to Spike-Wave Index.
Dilber B, Serdaroğlu E, Kanmaz S, et al.
Pediatric neurology 2024; (152()):79-86 doi:10.1016/j.pediatrneurol.2023.12.014.
PMID: 38237317 - 8
The Prevalence and Risk Factors of Electrical Status Epilepticus During Slow-Wave Sleep in Self-Limited Epilepsy With Centrotemporal Spikes.
Lu G, Cheng Y, Wang Y, et al.
Clinical EEG and neuroscience 2024; (55(2)):265-271 doi:10.1177/15500594231182758.
PMID: 37331959 - 9
ADHD and ADHD-related neural networks in benign epilepsy with centrotemporal spikes: A systematic review.
Aricò M, Arigliani E, Giannotti F, Romani M
Epilepsy & behavior : E&B 2020; (112()):107448 doi:10.1016/j.yebeh.2020.107448.
PMID: 32916583 - 10
Comparing cortical auditory processing in children with typical and atypical benign epilepsy with centrotemporal spikes: Electrophysiologic evidence of the role of non-rapid eye movement sleep abnormalities.
Filippini M, Boni A, Giannotta M, et al.
Epilepsia 2015; (56(5)):726-34 doi:10.1111/epi.12959.
PMID: 25809446 - 11
[The atypical developments of rolandic epilepsy are predictable complications].
Pesántez-Ríos G, Martínez-Bermejo A, Arcas J, et al.
Revista de neurologia 2015; (61(3)):106-13.
PMID: 26178515 - 12
Does Electrical Status Epilepticus in Sleep Adversely Affect Language in Self-Limiting Focal Epilepsies of Childhood?
Savaş M, Tunçer AM, Çelik İ, et al.
Noro psikiyatri arsivi 2023; (60(1)):62-67 doi:10.29399/npa.28086.
PMID: 36911556 - 13
Continuous epileptic negative myoclonus as the first seizure type in atypical benign epilepsy with centrotemporal spikes.
Yang L, Su Q, Xu N, et al.
Medicine 2020; (99(44)):e22965 doi:10.1097/MD.0000000000022965.
PMID: 33126368 - 14
Epileptic Negative Myoclonus as the First and Only Symptom in a Challenging Diagnosis of Benign Epilepsy With Centrotemporal Spikes.
Chen J, Zheng G, Guo H, et al.
Child neurology open 2017; (4()):2329048X17715965 doi:10.1177/2329048X17715965.
PMID: 28815192 - 15
Clinical Forms and GRIN2A Genotype of Severe End of Epileptic-Aphasia Spectrum Disorder.
Li X, Xie LL, Han W, et al.
Frontiers in pediatrics 2020; (8()):574803 doi:10.3389/fped.2020.574803.
PMID: 33240831 - 16
Developmental and epileptic encephalopathy with spike-wave activation in sleep (D/EE-SWAS): Clinical and treatment insights from a cohort of 50 children.
Kravljanac R, Striano P, Vucetic Tadic B, et al.
Seizure 2025; (133()):20-28 doi:10.1016/j.seizure.2025.09.019.
PMID: 41076959 - 17
Sleep and epilepsy syndromes.
Schmitt B
Neuropediatrics 2015; (46(3)):171-80 doi:10.1055/s-0035-1551574.
PMID: 25965811 - 18
A qualitative awake EEG score for the diagnosis of continuous spike and waves during sleep (CSWS) syndrome in self-limited focal epilepsy (SFE): A case-control study.
Aeby A, Santalucia R, Van Hecke A, et al.
Seizure 2021; (84()):34-39 doi:10.1016/j.seizure.2020.11.008.
PMID: 33276197 - 19
Seizures in self-limited epilepsy with centrotemporal spikes: video-EEG documentation.
Ferrari-Marinho T, Hamad APA, Casella EB, et al.
Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2020; (36(9)):1853-1857 doi:10.1007/s00381-020-04763-8.
PMID: 32661641 - 20
The fate of spikes in self-limited epilepsy with centrotemporal spikes: Are clinical and baseline EEG features effective?
Günay Ç, Sarikaya Uzan G, Özsoy Ö, et al.
Epilepsy research 2023; (193()):107165 doi:10.1016/j.eplepsyres.2023.107165.
PMID: 37201400
This page is for informational purposes only and does not constitute medical advice about your child's epilepsy. Do not stop or change seizure medication without guidance from your child's neurologist.
Get notified when new evidence is published on Self-limited epilepsy with centrotemporal spikes.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.